Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	SOX1 HOXA7 HOXB1 JUN HOXB3 NEUROD2 HOXD1 NFKB1 NFKB2 POU3F1 USF1 PBX3 AR GFI1 IRX4 TLX2	1.38e-07	1244	55	16	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	SOX1 HOXA7 HOXB1 JUN HOXB3 NEUROD2 HOXD1 NFKB1 NFKB2 POU3F1 USF1 PBX3 AR GFI1 IRX4 TLX2	1.85e-07	1271	55	16	GO:0000987
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	SOX1 HOXA7 HOXB1 JUN HOXB3 NEUROD2 NFKB1 NFKB2 PBX3 AR TLX2	2.99e-07	560	55	11	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	SOX1 HOXA7 HOXB1 JUN HOXB3 NEUROD2 NFKB1 NFKB2 PBX3 AR TLX2	3.33e-07	566	55	11	GO:0001216
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	SOX1 HOXA7 HOXB1 JUN HOXB3 NEUROD2 HOXD1 NFKB1 NFKB2 POU3F1 USF1 PBX3 AR GFI1 IRX4 TLX2	7.63e-07	1412	55	16	GO:0000981
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	SOX1 HOXA7 HOXB1 JUN HOXB3 NEUROD2 HOXD1 NFKB1 NFKB2 POU3F1 USF1 PBX3 AR GFI1 IRX4 TLX2	1.18e-06	1459	55	16	GO:0000977
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	SOX1 HOXA7 HOXB1 JUN HOXB3 NEUROD2 SUPT6H NFKB1 NFKB2 POU3F1 MAPK7 USF1 PBX3 AR TLX2	1.77e-06	1390	54	15	GO:0045944
GeneOntologyBiologicalProcess	embryo development	HOXA7 HOXB1 HSPG2 HOXB3 KRT8 HOXD1 SUPT6H DLG3 MAPK7 PBX3 AR GFI1 EPN2 TLX2	1.37e-05	1437	54	14	GO:0009790
GeneOntologyBiologicalProcess	negative regulation of calcidiol 1-monooxygenase activity	NFKB1 GFI1	2.01e-05	3	54	2	GO:0010956
GeneOntologyBiologicalProcess	embryonic skeletal system development	HOXA7 HOXB1 HSPG2 HOXB3 HOXD1	4.24e-05	148	54	5	GO:0048706
GeneOntologyBiologicalProcess	negative regulation of vitamin D biosynthetic process	NFKB1 GFI1	6.69e-05	5	54	2	GO:0010957
GeneOntologyBiologicalProcess	embryonic organ development	HOXA7 HOXB1 HSPG2 HOXB3 KRT8 PBX3 GFI1 EPN2	9.85e-05	561	54	8	GO:0048568
GeneOntologyBiologicalProcess	regulation of calcidiol 1-monooxygenase activity	NFKB1 GFI1	1.40e-04	7	54	2	GO:0060558
GeneOntologyBiologicalProcess	regulation of vitamin D biosynthetic process	NFKB1 GFI1	1.40e-04	7	54	2	GO:0060556
GeneOntologyBiologicalProcess	embryonic skeletal system morphogenesis	HOXA7 HOXB1 HSPG2 HOXB3	1.90e-04	109	54	4	GO:0048704
GeneOntologyBiologicalProcess	rhombomere development	HOXB1 HOXB3	2.39e-04	9	54	2	GO:0021546
GeneOntologyBiologicalProcess	vitamin D biosynthetic process	NFKB1 GFI1	2.99e-04	10	54	2	GO:0042368
GeneOntologyBiologicalProcess	negative regulation of vitamin metabolic process	NFKB1 GFI1	2.99e-04	10	54	2	GO:0046137
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase II	SOX1 HOXA7 JUN HOXB3 NFKB1 PRDM13 POU3F1 AR GFI1 IRX4	3.54e-04	1053	54	10	GO:0000122
GeneOntologyBiologicalProcess	brain development	SOX1 HOXB1 HSPG2 HOXB3 NEUROD2 PRDM13 POU3F1 PBX3 TRAPPC9	3.56e-04	859	54	9	GO:0007420
GeneOntologyBiologicalProcess	negative regulation of hormone biosynthetic process	NFKB1 GFI1	3.64e-04	11	54	2	GO:0032353
GeneOntologyBiologicalProcess	animal organ morphogenesis	SOX1 HOXA7 HOXB1 HSPG2 JUN HOXB3 NFKB1 PBX3 AR GFI1 IRX4	3.78e-04	1269	54	11	GO:0009887
GeneOntologyBiologicalProcess	pattern specification process	SOX1 HOXA7 HOXB1 HOXB3 PBX3 AR IRX4	4.23e-04	526	54	7	GO:0007389
GeneOntologyBiologicalProcess	embryonic morphogenesis	HOXA7 HOXB1 HSPG2 HOXB3 MAPK7 AR GFI1 TLX2	5.00e-04	713	54	8	GO:0048598
GeneOntologyBiologicalProcess	chordate embryonic development	HOXA7 HOXB1 HSPG2 HOXB3 KRT8 HOXD1 SUPT6H AR EPN2	5.25e-04	906	54	9	GO:0043009
GeneOntologyBiologicalProcess	head development	SOX1 HOXB1 HSPG2 HOXB3 NEUROD2 PRDM13 POU3F1 PBX3 TRAPPC9	5.82e-04	919	54	9	GO:0060322
GeneOntologyBiologicalProcess	fat-soluble vitamin biosynthetic process	NFKB1 GFI1	6.00e-04	14	54	2	GO:0042362
GeneOntologyBiologicalProcess	response to water	KRT8 PKD2L1	6.00e-04	14	54	2	GO:0009415
GeneOntologyBiologicalProcess	embryo development ending in birth or egg hatching	HOXA7 HOXB1 HSPG2 HOXB3 KRT8 HOXD1 SUPT6H AR EPN2	6.29e-04	929	54	9	GO:0009792
GeneOntologyBiologicalProcess	negative regulation of monooxygenase activity	NFKB1 GFI1	6.91e-04	15	54	2	GO:0032769
GeneOntologyCellularComponent	chromatin	SOX1 HOXA7 HOXB1 JUN HOXB3 ARID1B NEUROD2 HOXD1 NFKB1 NFKB2 POU3F1 USF1 PBX3 AR IRX4 TLX2	5.89e-07	1480	54	16	GO:0000785
GeneOntologyCellularComponent	I-kappaB/NF-kappaB complex	NFKB1 NFKB2	3.92e-05	4	54	2	GO:0033256
Domain	GOLGA6L	GOLGA6L10 GOLGA6L19 GOLGA6L9 GOLGA6L4	1.25e-09	6	58	4	IPR026737
Domain	Homeobox_CS	HOXA7 HOXB1 HOXB3 HOXD1 POU3F1 PBX3 IRX4 TLX2	1.04e-07	186	58	8	IPR017970
Domain	GOLGA2L5	GOLGA6L10 GOLGA6L19 GOLGA6L9 GOLGA6L4	2.48e-07	18	58	4	PF15070
Domain	Golgin_A	GOLGA6L10 GOLGA6L19 GOLGA6L9 GOLGA6L4	2.48e-07	18	58	4	IPR024858
Domain	Homeobox	HOXA7 HOXB1 HOXB3 HOXD1 POU3F1 PBX3 IRX4 TLX2	6.02e-07	234	58	8	PF00046
Domain	HOMEOBOX_1	HOXA7 HOXB1 HOXB3 HOXD1 POU3F1 PBX3 IRX4 TLX2	6.42e-07	236	58	8	PS00027
Domain	HOX	HOXA7 HOXB1 HOXB3 HOXD1 POU3F1 PBX3 IRX4 TLX2	6.63e-07	237	58	8	SM00389
Domain	HOMEOBOX_2	HOXA7 HOXB1 HOXB3 HOXD1 POU3F1 PBX3 IRX4 TLX2	7.06e-07	239	58	8	PS50071
Domain	Homeobox_dom	HOXA7 HOXB1 HOXB3 HOXD1 POU3F1 PBX3 IRX4 TLX2	7.06e-07	239	58	8	IPR001356
Domain	ANTENNAPEDIA	HOXA7 HOXB1 HOXB3 HOXD1	8.49e-07	24	58	4	PS00032
Domain	-	HOXA7 HOXB1 HOXB3 HOXD1 POU3F1 PBX3 IRX4 TLX2	2.50e-06	283	58	8	1.10.10.60
Domain	Homeodomain-like	HOXA7 HOXB1 HOXB3 HOXD1 POU3F1 PBX3 IRX4 TLX2	8.10e-06	332	58	8	IPR009057
Domain	Homeobox_metazoa	HOXA7 HOXB1 HOXB3 HOXD1 TLX2	8.70e-06	90	58	5	IPR020479
Domain	Homeobox_Antennapedia_CS	HOXA7 HOXB3 HOXD1	3.63e-05	21	58	3	IPR001827
Domain	RHD_CS	NFKB1 NFKB2	9.42e-05	5	58	2	IPR030492
Domain	IPT_NFkappaB	NFKB1 NFKB2	9.42e-05	5	58	2	IPR033926
Domain	RHD_dimer	NFKB1 NFKB2	4.20e-04	10	58	2	IPR032397
Domain	RHD_dimer	NFKB1 NFKB2	4.20e-04	10	58	2	PF16179
Domain	NFkB/Dor	NFKB1 NFKB2	4.20e-04	10	58	2	IPR000451
Domain	REL_1	NFKB1 NFKB2	4.20e-04	10	58	2	PS01204
Domain	RHD_DNA_bind_dom	NFKB1 NFKB2	4.20e-04	10	58	2	IPR011539
Domain	RHD_DNA_bind	NFKB1 NFKB2	4.20e-04	10	58	2	PF00554
Domain	REL_2	NFKB1 NFKB2	4.20e-04	10	58	2	PS50254
Domain	-	NFKB1 NFKB2	4.20e-04	10	58	2	2.60.40.340
Domain	IPT	NFKB1 NFKB2	3.16e-03	27	58	2	SM00429
Domain	DEATH	NFKB1 NFKB2	3.16e-03	27	58	2	SM00005
Domain	-	HSPG2 CELSR3 LMAN2	3.21e-03	95	58	3	2.60.120.200
Domain	EGF_LAM_2	HSPG2 CELSR3	3.90e-03	30	58	2	PS50027
Domain	EGF_LAM_1	HSPG2 CELSR3	3.90e-03	30	58	2	PS01248
Domain	Ig_E-set	FLNB NFKB1 NFKB2	4.14e-03	104	58	3	IPR014756
Domain	IPT	NFKB1 NFKB2	4.43e-03	32	58	2	IPR002909
Domain	Death	NFKB1 NFKB2	4.70e-03	33	58	2	PF00531
Domain	ConA-like_dom	HSPG2 CELSR3 LMAN2 SPSB2	4.76e-03	219	58	4	IPR013320
Domain	Laminin_EGF	HSPG2 CELSR3	5.28e-03	35	58	2	PF00053
Domain	EGF_Lam	HSPG2 CELSR3	5.28e-03	35	58	2	SM00180
Domain	Death_domain	NFKB1 NFKB2	6.20e-03	38	58	2	IPR000488
Domain	DEATH_DOMAIN	NFKB1 NFKB2	6.20e-03	38	58	2	PS50017
Domain	LAM_G_DOMAIN	HSPG2 CELSR3	6.20e-03	38	58	2	PS50025
Domain	Laminin_EGF	HSPG2 CELSR3	6.20e-03	38	58	2	IPR002049
Domain	Laminin_G_2	HSPG2 CELSR3	6.85e-03	40	58	2	PF02210
Domain	Keratin_I	KRT8 KRT35	8.25e-03	44	58	2	IPR002957
Domain	LamG	HSPG2 CELSR3	8.25e-03	44	58	2	SM00282
Pathway	REACTOME_DEVELOPMENTAL_BIOLOGY	SOX1 HOXB1 JUN HOXB3 KRT8 ARID1B HOXD1 KRTAP13-2 KRT35 NFKB1 PSMD1 DLG3 POU3F1 MAPK7 OCLN USF1 GFI1	1.18e-06	1432	46	17	M509
Pathway	WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3	JUN NFKB1 NFKB2 MAPK7	1.02e-04	75	46	4	M39568
Pathway	REACTOME_MYD88_MAL_TIRAP_CASCADE_INITIATED_ON_PLASMA_MEMBRANE	JUN NFKB1 NFKB2 MAPK7	1.66e-04	85	46	4	MM14645
Pathway	REACTOME_DEX_H_BOX_HELICASES_ACTIVATE_TYPE_I_IFN_AND_INFLAMMATORY_CYTOKINES_PRODUCTION	NFKB1 NFKB2	2.16e-04	7	46	2	MM14930
Pathway	REACTOME_IKBA_VARIANT_LEADS_TO_EDA_ID	NFKB1 NFKB2	2.16e-04	7	46	2	M27463
Pathway	REACTOME_DEX_H_BOX_HELICASES_ACTIVATE_TYPE_I_IFN_AND_INFLAMMATORY_CYTOKINES_PRODUCTION	NFKB1 NFKB2	2.16e-04	7	46	2	M27227
Pathway	PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY	JUN KRT8 USF1	2.53e-04	38	46	3	M229
Pathway	WP_NEURAL_CREST_DIFFERENTIATION	HOXB1 NFKB1 NFKB2 TLX2	2.75e-04	97	46	4	MM15926
Pathway	REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE	JUN NFKB1 NFKB2 MAPK7	2.98e-04	99	46	4	MM14660
Pathway	WP_NEURAL_CREST_DIFFERENTIATION	HOXB1 NFKB1 NFKB2 TLX2	3.22e-04	101	46	4	M39448
Pathway	WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING	JUN NFKB1 NFKB2	3.41e-04	42	46	3	M39452
Pathway	BIOCARTA_PCAF_PATHWAY	JUN NFKB1	3.70e-04	9	46	2	MM1533
Pathway	REACTOME_INTERLEUKIN_1_PROCESSING	NFKB1 NFKB2	3.70e-04	9	46	2	M27383
Pathway	REACTOME_INTERLEUKIN_1_PROCESSING	NFKB1 NFKB2	3.70e-04	9	46	2	MM15129
Pathway	REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE	JUN NFKB1 NFKB2 MAPK7	4.30e-04	109	46	4	M29565
Pathway	REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE	JUN NFKB1 NFKB2 MAPK7	4.30e-04	109	46	4	M27012
Pathway	BIOCARTA_KERATINOCYTE_PATHWAY	HOXA7 JUN NFKB1	4.47e-04	46	46	3	M19118
Pathway	BIOCARTA_KERATINOCYTE_PATHWAY	HOXA7 JUN NFKB1	4.47e-04	46	46	3	MM1428
Pathway	REACTOME_FORMATION_OF_THE_POSTERIOR_NEURAL_PLATE	SOX1 POU3F1	4.61e-04	10	46	2	M48036
Pathway	REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE	JUN NFKB1 NFKB2 MAPK7	5.27e-04	115	46	4	M27013
Pathway	REACTOME_FORMATION_OF_THE_ANTERIOR_NEURAL_PLATE	SOX1 POU3F1	5.62e-04	11	46	2	M48031
Pathway	WP_INCLUSION_BODY_MYOSITIS	NFKB1 NFKB2	5.62e-04	11	46	2	M42545
Pathway	REACTOME_TOLL_LIKE_RECEPTOR_4_TLR4_CASCADE	JUN NFKB1 NFKB2 MAPK7	6.58e-04	122	46	4	MM14640
Pathway	REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS	HOXB1 JUN HOXB3 HOXD1	6.58e-04	122	46	4	M29689
Pathway	WP_RANKLRANK_SIGNALING	JUN NFKB1 NFKB2	7.58e-04	55	46	3	M39667
Pathway	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM	FLNB JUN ILF3 NFKB1 NFKB2 PSMD1 MAPK7	7.79e-04	472	46	7	MM14539
Pathway	REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS	NFKB1 NFKB2	7.94e-04	13	46	2	MM14616
Pathway	BIOCARTA_PCAF_PATHWAY	JUN NFKB1	7.94e-04	13	46	2	M22007
Pathway	REACTOME_GASTRULATION	SOX1 PSMD1 POU3F1 OCLN	8.11e-04	129	46	4	M46433
Pathway	WP_ECTODYSPLASIN_A_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT	NFKB1 NFKB2	9.25e-04	14	46	2	MM15847
Pathway	REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION	NFKB1 NFKB2	9.25e-04	14	46	2	MM15641
Pathway	REACTOME_INTERLEUKIN_17_SIGNALING	JUN NFKB1 MAPK7	9.30e-04	59	46	3	MM15128
Pathway	BIOCARTA_CDMAC_PATHWAY	JUN NFKB1	1.06e-03	15	46	2	MM1358
Pathway	WP_MAPK_SIGNALING	FLNB JUN NFKB1 NFKB2 MAPK7	1.19e-03	246	46	5	M39597
Pathway	WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS	JUN NFKB1	1.21e-03	16	46	2	M42567
Pathway	REACTOME_THE_NLRP3_INFLAMMASOME	NFKB1 NFKB2	1.21e-03	16	46	2	M1063
Pathway	BIOCARTA_CDMAC_PATHWAY	JUN NFKB1	1.21e-03	16	46	2	M4388
Pathway	REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1	NFKB1 NFKB2	1.37e-03	17	46	2	M583
Pathway	BIOCARTA_41BB_PATHWAY	JUN NFKB1	1.54e-03	18	46	2	M2064
Pathway	BIOCARTA_41BB_PATHWAY	JUN NFKB1	1.54e-03	18	46	2	MM1511
Pathway	BIOCARTA_CARDIACEGF_PATHWAY	JUN NFKB1	1.54e-03	18	46	2	M7552
Pathway	WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY	JUN NFKB1	1.54e-03	18	46	2	M39478
Pathway	BIOCARTA_CARDIACEGF_PATHWAY	JUN NFKB1	1.54e-03	18	46	2	MM1479
Pathway	REACTOME_INTERLEUKIN_17_SIGNALING	JUN NFKB1 MAPK7	1.59e-03	71	46	3	M27382
Pathway	REACTOME_TOLL_LIKE_RECEPTOR_CASCADES	JUN NFKB1 NFKB2 MAPK7	1.60e-03	155	46	4	MM14665
Pathway	KEGG_MAPK_SIGNALING_PATHWAY	FLNB JUN NFKB1 NFKB2 MAPK7	1.71e-03	267	46	5	M10792
Pathway	BIOCARTA_ATM_PATHWAY	JUN NFKB1	1.72e-03	19	46	2	MM1351
Pathway	WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS	JUN NFKB1 NFKB2 AR	1.76e-03	159	46	4	M39373
Pathway	BIOCARTA_ATM_PATHWAY	JUN NFKB1	1.91e-03	20	46	2	M10628
Pathway	BIOCARTA_MAPK_PATHWAY	JUN NFKB1 MAPK7	1.94e-03	76	46	3	MM1433
Pathway	WP_EBV_LMP1_SIGNALING	NFKB1 NFKB2	2.10e-03	21	46	2	MM15923
Pathway	REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS	NFKB1 NFKB2	2.10e-03	21	46	2	M26978
Pathway	REACTOME_INFLAMMASOMES	NFKB1 NFKB2	2.10e-03	21	46	2	M1072
Pathway	REACTOME_SIGNALING_BY_INTERLEUKINS	JUN NFKB1 NFKB2 PSMD1 MAPK7	2.13e-03	281	46	5	MM15130
Pathway	REACTOME_TOLL_LIKE_RECEPTOR_CASCADES	JUN NFKB1 NFKB2 MAPK7	2.25e-03	170	46	4	M7494
Pathway	BIOCARTA_MAPK_PATHWAY	JUN NFKB1 MAPK7	2.32e-03	81	46	3	M13863
Pathway	WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING	NFKB1 NFKB2	2.52e-03	23	46	2	M39410
Pathway	WP_ESTROGEN_SIGNALING	JUN NFKB1	2.52e-03	23	46	2	M39672
Pathway	WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS	NFKB1 NFKB2	2.52e-03	23	46	2	M39862
Pathway	WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE	JUN NFKB1	2.52e-03	23	46	2	M39843
Pathway	WP_LDL_INFLUENCE_ON_CD14_AND_TLR4	NFKB1 NFKB2	2.52e-03	23	46	2	M45556
Pathway	BIOCARTA_TOLL_PATHWAY	JUN NFKB1	2.75e-03	24	46	2	MM1518
Pathway	BIOCARTA_STRESS_PATHWAY	JUN NFKB1	2.75e-03	24	46	2	MM1515
Pathway	BIOCARTA_STRESS_PATHWAY	JUN NFKB1	2.75e-03	24	46	2	M9670
Pathway	REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION	NFKB1 NFKB2	2.98e-03	25	46	2	M940
Pathway	BIOCARTA_TOLL_PATHWAY	JUN NFKB1	2.98e-03	25	46	2	M984
Pubmed	A census of human transcription factors: function, expression and evolution.	SOX1 HOXA7 HOXB1 JUN HOXB3 NEUROD2 HOXD1 NFKB1 NFKB2 POU3F1 USF1 PBX3 AR IRX4 TLX2	1.66e-11	908	58	15	19274049
Pubmed	Hox-1.11 and Hox-4.9 homeobox genes.	HOXA7 HOXB1 HOXB3 HOXD1	6.88e-09	14	58	4	1348361
Pubmed	Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors.	JUN NFKB1 NFKB2	1.76e-08	4	58	3	7823959
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	HOXA7 HOXB1 JUN NEUROD2 HOXD1 NFKB2 POU3F1 USF1 GFI1 TLX2	2.15e-08	544	58	10	28473536
Pubmed	Organization of human class I homeobox genes.	HOXA7 HOXB1 HOXB3 HOXD1	4.98e-08	22	58	4	2576652
Pubmed	HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium.	JUN NFKB1 NFKB2	8.77e-08	6	58	3	12485413
Pubmed	The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the beta-chemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: role of SP-1, AP-1, and NF-kappaB consensus sites.	JUN NFKB1 NFKB2	1.53e-07	7	58	3	10644332
Pubmed	The branchial Hox code and its implications for gene regulation, patterning of the nervous system and head evolution.	HOXB1 HOXB3 HOXD1	2.45e-07	8	58	3	1688181
Pubmed	In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor.	JUN NFKB1 NFKB2	2.45e-07	8	58	3	7690421
Pubmed	The thyroid transcription factor-1 gene is a candidate target for regulation by Hox proteins.	HOXB1 HOXB3 HOXD1	3.67e-07	9	58	3	7913891
Pubmed	Local alterations of Krox-20 and Hox gene expression in the hindbrain suggest lack of rhombomeres 4 and 5 in homozygote null Hoxa-1 (Hox-1.6) mutant embryos.	HOXB1 HOXB3 HOXD1	3.67e-07	9	58	3	8102800
Pubmed	Complete mutation analysis panel of the 39 human HOX genes.	HOXA7 HOXB1 HOXB3 HOXD1	4.93e-07	38	58	4	11857506
Pubmed	Atlas of Hox gene expression in the developing kidney.	HOXA7 HOXB1 HOXB3 HOXD1	4.93e-07	38	58	4	15042701
Pubmed	Lysine demethylase 7a regulates murine anterior-posterior development by modulating the transcription of Hox gene cluster.	HOXA7 HOXB1 HOXB3 HOXD1	5.48e-07	39	58	4	33257809
Pubmed	Quantification of Hox and surfactant protein-B transcription during murine lung development.	HOXA7 HOXB1 HOXB3 HOXD1	6.08e-07	40	58	4	19204410
Pubmed	Lin28a/let-7 pathway modulates the Hox code via Polycomb regulation during axial patterning in vertebrates.	HOXA7 HOXB1 HOXB3 HOXD1	6.73e-07	41	58	4	32479258
Pubmed	Reduction of Hox gene expression by histone H1 depletion.	HOXA7 HOXB1 HOXB3 HOXD1	8.18e-07	43	58	4	22701719
Pubmed	Nomenclature for human homeobox genes.	HOXA7 HOXB1 HOXB3 HOXD1	8.99e-07	44	58	4	1973146
Pubmed	Vertebrate homeobox gene nomenclature.	HOXA7 HOXB1 HOXB3 HOXD1	1.18e-06	47	58	4	1358459
Pubmed	Long-range regulation by shared retinoic acid response elements modulates dynamic expression of posterior Hoxb genes in CNS development.	HOXA7 HOXB1 HOXB3	1.24e-06	13	58	3	24525295
Pubmed	An Interaction Landscape of Ubiquitin Signaling.	HSPG2 FLNB USP13 ILF3 ANTXR1 PSMD1 HERC2 EPN2	1.32e-06	481	58	8	28190767
Pubmed	New insights into the role of Jmjd3 and Utx in axial skeletal formation in mice.	HOXA7 HOXB1 HOXB3 HOXD1	1.51e-06	50	58	4	28188179
Pubmed	A dynamic expression survey identifies transcription factors relevant in mouse digestive tract development.	HOXA7 HOXB1 HOXB3 HOXD1 AR	1.64e-06	118	58	5	16971476
Pubmed	A distinct Hox code for the branchial region of the vertebrate head.	HOXB1 HOXB3 HOXD1	1.97e-06	15	58	3	1682814
Pubmed	Differential requirement for p56lck in HIV-tat versus TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal kinase, and apoptosis.	JUN NFKB1 NFKB2	1.97e-06	15	58	3	10799874
Pubmed	TRIM30 modulates Interleukin-22-regulated papillary thyroid Cancer cell migration and invasion by targeting Sox17 for K48-linked Polyubiquitination.	JUN ILF3 FLG2	2.43e-06	16	58	3	31823782
Pubmed	TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.	JUN KRT8 ARID1B MOGS NFKB1 NFKB2 LMAN2 HERC2 PBX3 GFI1	2.69e-06	922	58	10	27609421
Pubmed	Quantitative dissection and modeling of the NF-κB p100-p105 module reveals interdependent precursor proteolysis.	NFKB1 NFKB2	2.73e-06	2	58	2	25482563
Pubmed	Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype.	NFKB1 NFKB2	2.73e-06	2	58	2	28368397
Pubmed	Cyclooxygenase-2 gene transcription in a macrophage model of inflammation.	JUN NFKB1	2.73e-06	2	58	2	17114486
Pubmed	Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption.	NFKB1 NFKB2	2.73e-06	2	58	2	12568403
Pubmed	Transplant-induced reactivation of murine cytomegalovirus immediate early gene expression is associated with recruitment of NF-κB and AP-1 to the major immediate early promoter.	JUN NFKB1	2.73e-06	2	58	2	26795571
Pubmed	Maternal warmth buffers the effects of low early-life socioeconomic status on pro-inflammatory signaling in adulthood.	JUN NFKB1	2.73e-06	2	58	2	20479762
Pubmed	EV71 induces COX-2 expression via c-Src/PDGFR/PI3K/Akt/p42/p44 MAPK/AP-1 and NF-kappaB in rat brain astrocytes.	JUN NFKB1	2.73e-06	2	58	2	20333648
Pubmed	Activator protein 1 is a key terminal mediator of inflammation-induced preterm labor in mice.	JUN NFKB1	2.73e-06	2	58	2	24497579
Pubmed	Repression of NF-kappaB and activation of AP-1 enhance apoptosis in prostate cancer cells.	JUN NFKB1	2.73e-06	2	58	2	19123467
Pubmed	Cultivated ginseng suppresses ultraviolet B-induced collagenase activation via mitogen-activated protein kinases and nuclear factor κB/activator protein-1-dependent signaling in human dermal fibroblasts.	JUN NFKB1	2.73e-06	2	58	2	22749179
Pubmed	NF-kappaB to the rescue: RELs, apoptosis and cellular transformation.	NFKB1 NFKB2	2.73e-06	2	58	2	10354583
Pubmed	Osteoclast precursor interaction with bone matrix induces osteoclast formation directly by an interleukin-1-mediated autocrine mechanism.	NFKB1 NFKB2	2.73e-06	2	58	2	18250170
Pubmed	New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases.	NFKB1 NFKB2	2.73e-06	2	58	2	9895331
Pubmed	The long non-coding RNA FLJ46906 binds to the transcription factors NF-κB and AP-1 and regulates expression of aging-associated genes.	JUN NFKB1	2.73e-06	2	58	2	30125263
Pubmed	Ectopic nuclear reorganisation driven by a Hoxb1 transgene transposed into Hoxd.	HOXB1 HOXD1	2.73e-06	2	58	2	18252796
Pubmed	c-Jun N-Terminal Phosphorylation: Biomarker for Cellular Stress Rather than Cell Death in the Injured Cochlea.	JUN GFI1	2.73e-06	2	58	2	27257624
Pubmed	How do nuclear factor kappa B (NF-κB)1 and NF-κB2 defects lead to the incidence of clinical and immunological manifestations of inborn errors of immunity?	NFKB1 NFKB2	2.73e-06	2	58	2	36706462
Pubmed	Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP.	JUN AR	2.73e-06	2	58	2	9211894
Pubmed	ncRNA-mediated overexpression of ubiquitin-specific proteinase 13 contributes to the progression of prostate cancer via modulating AR signaling, DNA damage repair and immune infiltration.	USP13 AR	2.73e-06	2	58	2	36564767
Pubmed	Downregulation of cellular c-Jun N-terminal protein kinase and NF-κB activation by berberine may result in inhibition of herpes simplex virus replication.	JUN NFKB1	2.73e-06	2	58	2	24913175
Pubmed	Related subunits of NF-kappa B map to two distinct loci associated with translocations in leukemia, NFKB1 and NFKB2.	NFKB1 NFKB2	2.73e-06	2	58	2	1612589
Pubmed	NF-κB-to-AP-1 switch: a mechanism regulating transition from endothelial barrier injury to repair in endotoxemic mice.	JUN NFKB1	2.73e-06	2	58	2	24986487
Pubmed	The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas.	NFKB1 NFKB2	2.73e-06	2	58	2	16751281
Pubmed	Chlamydia pneumoniae infection and hyperlipidaemia-induced expression of P50 and c-Fos in the heart of C57BL6J mice.	JUN NFKB1	2.73e-06	2	58	2	18468197
Pubmed	Expression of transcription factors NF-kappaB and AP-1 in nasal polyposis.	JUN NFKB1	2.73e-06	2	58	2	18352974
Pubmed	Monitoring a nuclear factor-κB signature of drug resistance in multiple myeloma.	NFKB1 NFKB2	2.73e-06	2	58	2	21846842
Pubmed	Activation of transcription factors NF-kappaB and AP-1 and their relations with apoptosis associated-proteins in hepatocellular carcinoma.	JUN NFKB1	2.73e-06	2	58	2	15991283
Pubmed	Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells.	NFKB2 AR	2.73e-06	2	58	2	20388792
Pubmed	Astragaloside IV inhibits NF- κ B activation and inflammatory gene expression in LPS-treated mice.	JUN NFKB1	2.73e-06	2	58	2	25960613
Pubmed	c-Jun can mediate androgen receptor-induced transactivation.	JUN AR	2.73e-06	2	58	2	8798722
Pubmed	NF-kappa B binds to the immunoglobulin S gamma 3 region in vivo during class switch recombination.	NFKB1 NFKB2	2.73e-06	2	58	2	17109470
Pubmed	Requirement for NF-kappaB in osteoclast and B-cell development.	NFKB1 NFKB2	2.73e-06	2	58	2	9407039
Pubmed	Negative-strand RNA transcripts are produced in human immunodeficiency virus type 1-infected cells and patients by a novel promoter downregulated by Tat.	NFKB1 USF1	2.73e-06	2	58	2	8289399
Pubmed	AP-1 and NF-κB synergize to transcriptionally activate latent HIV upon T-cell receptor activation.	JUN NFKB1	2.73e-06	2	58	2	33421101
Pubmed	Transcriptional activity of c-Jun is critical for the suppression of AR function.	JUN AR	2.73e-06	2	58	2	23523566
Pubmed	Cell-lineage specificity and role of AP-1 in the prostate fibroblast androgen receptor cistrome.	JUN AR	2.73e-06	2	58	2	27634452
Pubmed	NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity.	JUN NFKB1	2.73e-06	2	58	2	15314185
Pubmed	[Effects of CpG-ODN combined with HBsAg on the phenotype, function and the activity of NF-kappa B and AP-1 of monocyte-derived dendritic cells in chronic hepatitis B patients].	JUN NFKB1	2.73e-06	2	58	2	18304423
Pubmed	Analysis of NFKB1 and NFKB2 gene expression in the blood of patients with sudden sensorineural hearing loss.	NFKB1 NFKB2	2.73e-06	2	58	2	36773447
Pubmed	Sodium lactate increases LPS-stimulated MMP and cytokine expression in U937 histiocytes by enhancing AP-1 and NF-kappaB transcriptional activities.	JUN NFKB1	2.73e-06	2	58	2	15941782
Pubmed	Cycling hypoxia promotes a pro-inflammatory phenotype in macrophages via JNK/p65 signaling pathway.	JUN NFKB1	2.73e-06	2	58	2	31964911
Pubmed	Isolation and analysis of embryonic expression of Hox-4.9, a member of the murine labial-like gene family.	HOXB1 HOXD1	2.73e-06	2	58	2	1356009
Pubmed	NF-{kappa}B is transported into the nucleus by importin {alpha}3 and importin {alpha}4.	NFKB1 NFKB2	2.73e-06	2	58	2	15677444
Pubmed	Combination of linkage mapping and microarray-expression analysis identifies NF-kappaB signaling defect as a cause of autosomal-recessive mental retardation.	NFKB1 TRAPPC9	2.73e-06	2	58	2	20004764
Pubmed	Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.	NFKB1 NFKB2	2.73e-06	2	58	2	9359707
Pubmed	Screening large numbers of expression patterns of transcription factors in late stages of the mouse thymus.	HOXB1 HOXB3 KRT8 POU3F1 PBX3 IRX4	5.14e-06	263	58	6	20932939
Pubmed	Schwann cell myelination requires integration of laminin activities.	HSPG2 JUN POU3F1	5.73e-06	21	58	3	22767514
Pubmed	Cdx is crucial for the timing mechanism driving colinear Hox activation and defines a trunk segment in the Hox cluster topology.	HOXA7 HOXB1 HOXD1	7.61e-06	23	58	3	28041967
Pubmed	USF1-ATRAP-PBX3 Axis Promote Breast Cancer Glycolysis and Malignant Phenotype by Activating AKT/mTOR Signaling.	USF1 PBX3	8.19e-06	3	58	2	35414770
Pubmed	Regulation of the G2-M cell cycle progression by the ERK5-NFkappaB signaling pathway.	NFKB1 MAPK7	8.19e-06	3	58	2	17452529
Pubmed	Regulation of stimulus-induced interleukin-8 gene transcription in human adrenocortical carcinoma cells - Role of AP-1 and NF-κB.	JUN NFKB1	8.19e-06	3	58	2	31634687
Pubmed	Dimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3).	NFKB1 NFKB2	8.19e-06	3	58	2	8441377
Pubmed	Clinorotation upregulates inducible nitric oxide synthase by inhibiting AP-1 activation in human umbilical vein endothelial cells.	JUN NFKB1	8.19e-06	3	58	2	19306295
Pubmed	CDK5 functions as a tumor promoter in human colorectal cancer via modulating the ERK5-AP-1 axis.	JUN MAPK7	8.19e-06	3	58	2	27735944
Pubmed	Nuclear transcription factor-kappaB as a target for cancer drug development.	NFKB1 NFKB2	8.19e-06	3	58	2	12040437
Pubmed	The NF-kappa B and I kappa B proteins: new discoveries and insights.	NFKB1 NFKB2	8.19e-06	3	58	2	8717528
Pubmed	NIBP, a novel NIK and IKK(beta)-binding protein that enhances NF-(kappa)B activation.	NFKB1 TRAPPC9	8.19e-06	3	58	2	15951441
Pubmed	Enteroaggregative Escherichia coli infection induces IL-8 production via activation of mitogen-activated protein kinases and the transcription factors NF-kappaB and AP-1 in INT-407 cells.	JUN NFKB1	8.19e-06	3	58	2	19898747
Pubmed	Inhibition of Egr-1 by siRNA in prostate carcinoma cell lines is associated with decreased expression of AP-1 and NF-κB.	JUN NFKB1	8.19e-06	3	58	2	21743958
Pubmed	The IkappaB kinase complex and NF-kappaB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1.	JUN NFKB1	8.19e-06	3	58	2	15226448
Pubmed	Motif module map reveals enforcement of aging by continual NF-kappaB activity.	NFKB1 NFKB2	8.19e-06	3	58	2	18055696
Pubmed	Induction of mouse c-src in RAW264 cells is dependent on AP-1 and NF-kappaB and important for progression to multinucleated cell formation.	JUN NFKB1	8.19e-06	3	58	2	15541355
Pubmed	Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B.	JUN NFKB1	8.19e-06	3	58	2	12145210
Pubmed	Protective effect of kobophenol A on nitric oxide-induced cell apoptosis in human osteoblast-like MG-63 cells: involvement of JNK, NF-κB and AP-1 pathways.	JUN NFKB1	8.19e-06	3	58	2	21511059
Pubmed	The Effects of NF-κB and c-Jun/AP-1 on the Expression of Prothrombotic and Proinflammatory Molecules Induced by Anti-β2GPI in Mouse.	JUN NFKB1	8.19e-06	3	58	2	26829121
Pubmed	Transcriptional regulation of increased CCL2 expression in pulmonary fibrosis involves nuclear factor-κB and activator protein-1.	JUN NFKB1	8.19e-06	3	58	2	23583295
Pubmed	Differential inhibition of UVB-induced AP-1 and NF-kappaB transactivation by components of the jun bZIP domain.	JUN NFKB1	8.19e-06	3	58	2	15791649
Pubmed	NF-κB: an essential transcription factor in psoriasis.	NFKB1 NFKB2	8.19e-06	3	58	2	23219896
Pubmed	NFkappaB1/p50 is not required for tumor necrosis factor-stimulated growth of primary mammary epithelial cells: implications for NFkappaB2/p52 and RelB.	NFKB1 NFKB2	8.19e-06	3	58	2	17008396
Pubmed	Identification of endogenous glucocorticoid repressed genes differentially regulated by a glucocorticoid receptor mutant able to separate between nuclear factor-kappaB and activator protein-1 repression.	JUN NFKB1	8.19e-06	3	58	2	15550679
Pubmed	Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid.	JUN NFKB1	8.19e-06	3	58	2	15944151
Pubmed	Necrotic cells influence migration and invasion of glioblastoma via NF-κB/AP-1-mediated IL-8 regulation.	JUN NFKB1	8.19e-06	3	58	2	27076368
Pubmed	Signaling mediated by the NF-κB sub-units NF-κB1, NF-κB2 and c-Rel differentially regulate Helicobacter felis-induced gastric carcinogenesis in C57BL/6 mice.	NFKB1 NFKB2	8.19e-06	3	58	2	23975431
Interaction	ERG interactions	PRR12 JUN ARID1B ILF3 NEUROD2 HERC2 AR	2.71e-06	223	56	7	int:ERG
Interaction	MEIS1 interactions	HOXA7 HOXB1 PBX3 TLX2	1.31e-05	52	56	4	int:MEIS1
Interaction	KLF5 interactions	PRR12 JUN ARID1B NFKB1 FLG2 AR	1.65e-05	195	56	6	int:KLF5
Interaction	ETS1 interactions	JUN ARID1B NFKB1 MAPK7 AR	2.15e-05	121	56	5	int:ETS1
Interaction	GSK3B interactions	BICD2 JUN DNAJC13 MOGS NFKB1 NFKB2 PSMD1 LMAN2 HERC2 AR GFI1	2.24e-05	868	56	11	int:GSK3B
Interaction	HDAC4 interactions	BICD2 PRR12 ILF3 KRT35 NFKB1 NFKB2 HERC2 GOLGA6L9 AR TRAPPC9	3.38e-05	744	56	10	int:HDAC4
Interaction	UNC5CL interactions	BICD2 KRTAP13-2 NFKB1	3.46e-05	23	56	3	int:UNC5CL
Interaction	HOXD1 interactions	HOXB1 HOXD1	7.54e-05	5	56	2	int:HOXD1
Cytoband	15q25.2	GOLGA6L10 GOLGA6L9 MEX3B GOLGA6L4	2.54e-07	43	57	4	15q25.2
Cytoband	2p13.1	MOGS ANTXR1 TLX2	1.06e-05	34	57	3	2p13.1
Cytoband	Ensembl 112 genes in cytogenetic band chr15q25	GOLGA6L10 GOLGA6L9 MEX3B GOLGA6L4	4.86e-05	160	57	4	chr15q25
Cytoband	17q21.3	HOXB1 HOXB3	1.80e-04	16	57	2	17q21.3
Cytoband	Ensembl 112 genes in cytogenetic band chr2p13	MOGS ANTXR1 TLX2	7.20e-04	140	57	3	chr2p13
Cytoband	10q24	NFKB2 PKD2L1	8.78e-04	35	57	2	10q24
GeneFamily	HOXL subclass homeoboxes	HOXA7 HOXB1 HOXB3 HOXD1	5.69e-06	52	41	4	518
GeneFamily	Ankyrin repeat domain containing\|NF-kappa B complex subunits	NFKB1 NFKB2	5.00e-05	5	41	2	1254
GeneFamily	TALE class homeoboxes and pseudogenes	PBX3 IRX4	1.58e-03	26	41	2	526
Coexpression	BENPORATH_EED_TARGETS	SOX1 HOXA7 HOXB1 JUN HOXB3 NEUROD2 HOXD1 PRDM13 POU3F1 RBM24 GFI1 IRX4 TLX2	2.67e-07	1059	56	13	M7617
Coexpression	HOFFMAN_CLOCK_TARGETS_UP	HOXA7 JUN ANTXR1	1.10e-06	10	56	3	M2063
Coexpression	AIZARANI_LIVER_C39_EPCAM_POS_BILE_DUCT_CELLS_4	FLNB KRT8 NFKB1 NFKB2 OCLN	4.61e-05	184	56	5	M39135
Coexpression	BENPORATH_SUZ12_TARGETS	SOX1 HOXB1 JUN HOXB3 NEUROD2 HOXD1 POU3F1 GFI1 IRX4 TLX2	6.02e-05	1035	56	10	M9898
Coexpression	RIZ_ERYTHROID_DIFFERENTIATION_12HR	JUN PBX3 AR	6.27e-05	36	56	3	M4389
Coexpression	RIZ_ERYTHROID_DIFFERENTIATION_12HR	JUN PBX3 AR	6.27e-05	36	56	3	MM513
Coexpression	GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN	HOXA7 JUN HOXD1 GHITM LMAN2	6.69e-05	199	56	5	M6654
Coexpression	BENPORATH_PRC2_TARGETS	HOXB1 JUN HOXB3 NEUROD2 HOXD1 POU3F1 IRX4 TLX2	6.81e-05	650	56	8	M8448
Coexpression	MIKKELSEN_IPS_WITH_HCP_H3K27ME3	HOXB1 HOXB3 PRDM13 GFI1	7.06e-05	103	56	4	M1967
Coexpression	MIKKELSEN_IPS_WITH_HCP_H3K27ME3	HOXB1 HOXB3 PRDM13 GFI1	7.89e-05	106	56	4	MM1265
Coexpression	MULLIGHAN_NPM1_SIGNATURE_3_UP	HOXA7 HOXB3 GHITM POU3F1 PIP4K2C PBX3	7.90e-05	335	56	6	M10277
Coexpression	BENPORATH_ES_WITH_H3K27ME3	HOXA7 HOXB1 JUN HOXB3 NEUROD2 HOXD1 PRDM13 POU3F1 IRX4 TLX2	1.12e-04	1115	56	10	M10371
Coexpression	DESCARTES_ORGANOGENESIS_NEURAL_PROGENITOR_CELLS	HOXA7 PRDM13 PKD2L1	1.69e-04	50	56	3	MM3639
ToppCell	severe-MAIT\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	JUN USP13 PRDM13 RBM24 PZP	6.25e-06	200	58	5	1daf43f1bdd49585dce5e957820554d7f3c1bd4a
ToppCell	TCGA-Blood_and_Bone_Marrow-Primary_Blood_Derived_Cancer_-_Peripheral_Blood-Leukemia-Acute_Myeloid_Leukemia-6\|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9	HOXA7 HOXB3 OCLN PBX3	2.14e-05	125	58	4	dd59d6ca4d36f9453eb1b1f260fab36c5d641cb2
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ANTXR1 DLG3 RBM24 MEX3B	5.49e-05	159	58	4	7cda111bb98f1241989e49d490bdf51a712ea589
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	FLNB USP13 ANTXR1 AR	5.63e-05	160	58	4	8aaf6ac4f33ea291387fdbf9ff1a91d559391774
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3\|GI_small-bowel / Manually curated celltypes from each tissue	HOXA7 FLNB RBM24 IRX4	6.49e-05	166	58	4	773673a5d0430640439845b264740bfbbdad0cb2
ToppCell	Entopeduncular-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Serpinb1a_(Serpinb1a)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	HOXD1 PRDM13 PZP	6.60e-05	60	58	3	48adafeec1810bce5f118fa63d4a8ee7ab9ca0f7
ToppCell	Entopeduncular-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Serpinb1a_(Serpinb1a)-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	HOXD1 PRDM13 PZP	6.60e-05	60	58	3	a83afb89dbfc2e1cdfce57320d89c980bd8fb820
ToppCell	3'_v3-Lung-Lymphocytic_Invariant-Inducer-like-ILC3\|Lung / Manually curated celltypes from each tissue	HOXA7 NFKB1 RBM24 MEX3B	6.64e-05	167	58	4	0614d077b47a87f726068615548d0b0a216627be
ToppCell	mild-Others-CD34+_GATA2+_cells\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	HOXA7 HSPG2 KRT8 MEX3B	7.45e-05	172	58	4	379f6f271e653d5e404851e51a189bd582bb0f43
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-B_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HOXA7 JUN MEX3B EPN2	7.62e-05	173	58	4	0a0cd40bb5f61431fe34758626c8a63ec610a8a5
ToppCell	COVID-19_Severe-MAIT\|COVID-19_Severe / Disease condition and Cell class	JUN PRDM13 RBM24 PZP	8.32e-05	177	58	4	8eb69041f482b58325e3539f607923f7b1fa5977
ToppCell	severe-Others-CD34+_GATA2+_cells\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	HOXA7 HSPG2 KRT8 MEX3B	8.69e-05	179	58	4	dd789a1b7327d6f9ed5272f3eb54bd43f7ae8d78
ToppCell	critical-Myeloid-Mast_cell\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	HSPG2 HOXB3 JPH4 GFI1	9.07e-05	181	58	4	f0d81ae74d3f32979624a94b2ef93774831a7970
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	JUN PRDM13 RBM24 PZP	9.27e-05	182	58	4	f30e5a21b49f30b82e2b6f1fd2daefd805a40083
ToppCell	COVID-19_Severe-Lymphoid_T/NK-MAIT\|COVID-19_Severe / Disease group, lineage and cell class	JUN PRDM13 RBM24 PZP	9.27e-05	182	58	4	19045db5c726c06ec6e4feb4311633c8164ddb3c
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	JUN PRDM13 RBM24 PZP	9.27e-05	182	58	4	1444cdc4522a70a40d697ccadf54cf26d327ade0
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	JUN PRDM13 RBM24 PZP	9.27e-05	182	58	4	cccac9f85825f4e310b86e37ee6320769a670501
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	JUN PRDM13 RBM24 PZP	9.27e-05	182	58	4	49eced222e8f90c2b59bcc7d56b62c3e703fcce5
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PSMD1 PBX3 AR EPN2	9.47e-05	183	58	4	3ef9ac1ae13b6172f9121ab1c129ecaa0fef460f
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CELSR3 HOXD1 RBM24 TLX2	1.07e-04	189	58	4	3f5522be3e24dcdb6272f18cee2f239dfdeff9ad
ToppCell	Severe-B_activate-7\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	JUN PILRB NFKB1 NFKB2	1.09e-04	190	58	4	67e6c8a5a8724bdf2861fd76a711319dfc71d47a
ToppCell	15-Trachea-Epithelial-Neuroendocrine\|Trachea / Age, Tissue, Lineage and Cell class	SOX1 JPH4 CELSR3 PKD2L1	1.12e-04	191	58	4	76311fa5f3ae9bb27cf04387a8c92300f2888c28
ToppCell	15\|World / Age, Tissue, Lineage and Cell class	FLNB JUN OCLN USF1	1.16e-04	193	58	4	a8ad0de955494d6f5929dc44ba46627d06d95453
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CELSR3 HOXD1 RBM24 TLX2	1.19e-04	194	58	4	5bd0f739aa75f387cca7c3b2686493ee2d1ee968
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HOXA7 HOXB3 PIP4K2C MEX3B	1.19e-04	194	58	4	4e93bd903cddfd0c8f220b6a35b449895de4119b
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-MAIT\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	JUN PILRB PRDM13 RBM24	1.21e-04	195	58	4	59164d115a0928cc9b79c7661c7190ad695f9d80
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-MAIT\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	JUN PILRB PRDM13 RBM24	1.21e-04	195	58	4	c7b54b210cc2c8ddaefebfba74381adb2ca698b8
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-MAIT-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	JUN PILRB PRDM13 RBM24	1.21e-04	195	58	4	e173a713d273b135db4f71bdcaada3b0e55d74f1
ToppCell	3'_v3-blood-Lymphocytic_NK-NK_CD56bright_CD16-\|blood / Manually curated celltypes from each tissue	FLNB PILRB NFKB1 NFKB2	1.21e-04	195	58	4	1470f562ebcfe7da367964ecfd6c7f43bcdb4a73
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HOXB3 CELSR3 HOXD1 TLX2	1.21e-04	195	58	4	b25c534fc6320d4da6437ef1b27e32a5d5256f3e
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-MAIT-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	JUN PILRB PRDM13 RBM24	1.21e-04	195	58	4	a8fd42ff6c2bd80d0e3f20fe3bbf7d113b399df1
ToppCell	AT2_cells-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	JUN USP13 KRT8 OCLN	1.28e-04	198	58	4	8a1f984e46f4fa5be33027b9dbaa2ca060a2245d
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Neuronal\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	NEUROD2 POU3F1 RBM24 MEX3B	1.28e-04	198	58	4	076c862f2a723f0361749377561cae902068b1a0
ToppCell	3'-Adult-Distal_Rectal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLNB KRT8 ARID1B KRTAP13-2	1.28e-04	198	58	4	7ad7726fc405806b1d7824f58548073ea5e0c70b
ToppCell	3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLNB KRT8 ARID1B KRTAP13-2	1.28e-04	198	58	4	1fbec311f2c987ca90a023a5989128c05aa12d5c
ToppCell	BAL-Severe-Epithelial-Epithelial-AT1/AT2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HSPG2 KRT8 HOXD1 OCLN	1.28e-04	198	58	4	aed0476248e9637897eefb1623ec4035f2dacd82
ToppCell	BAL-Severe-Epithelial-Epithelial-AT1/AT2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HSPG2 KRT8 HOXD1 OCLN	1.28e-04	198	58	4	691a2f1779225e5519155460eeb6a2aac5f67a92
ToppCell	BAL-Severe-Epithelial-Epithelial-AT1/AT2\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	HSPG2 KRT8 HOXD1 OCLN	1.28e-04	198	58	4	e115eea04012e9e492e923ed080e1723c38d14fd
ToppCell	BAL-Severe-Epithelial-Epithelial-AT1/AT2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HSPG2 KRT8 HOXD1 OCLN	1.28e-04	198	58	4	33d1e0b6f57663544bee0ffdde83a65da764d44c
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KRT8 PKD2L1 AR SPSB2	1.28e-04	198	58	4	dd0465b45b02cb8edf0914d19afb52fcaaeb012c
ToppCell	3'-Adult-Distal_Rectal-Epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLNB KRT8 ARID1B KRTAP13-2	1.28e-04	198	58	4	ceede961ad9af6a3159db7efaa5087bf38aafc2d
ToppCell	Severe_COVID-19-Epithelial-AT1/AT2\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	HSPG2 KRT8 HOXD1 OCLN	1.28e-04	198	58	4	43e33d28d9de5033bd00d39be953542a225236ed
ToppCell	3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLNB KRT8 ARID1B KRTAP13-2	1.28e-04	198	58	4	4f26a60e99f42343e5af7221723e108a1a1b7827
ToppCell	COVID-19-COVID-19_Mild-Others-HSPC\|COVID-19_Mild / Disease, condition lineage and cell class	HOXA7 HSPG2 KRT8 MEX3B	1.31e-04	199	58	4	0230103c37ae3aff58240739b89f2c36b1e39a69
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	JUN KRT8 POU3F1 IRX4	1.31e-04	199	58	4	c88a28a73f54dc571f2ff1e4b55073f83cbead2c
ToppCell	COVID-19-COVID-19_Severe-Others-HSPC\|COVID-19_Severe / Disease, condition lineage and cell class	HOXA7 HSPG2 KRT8 MEX3B	1.31e-04	199	58	4	25de67b6c9c8d6bb9a538e071a40ef865906c95d
ToppCell	severe-MAIT\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	JUN PRDM13 RBM24 PZP	1.33e-04	200	58	4	8a849d0ef244aa2666da2d31bd0731fb04e40911
Computational	Genes in the cancer module 123.	HOXB1 JUN ILF3 NFKB1 NFKB2 POU3F1 AR	3.03e-05	247	40	7	MODULE_123
Computational	Genes in the cancer module 197.	HOXA7 JUN ILF3 NFKB1 GFI1	4.36e-04	174	40	5	MODULE_197
Drug	2,2',4,6,6'-pentachlorobiphenyl	JUN NFKB1 OCLN AR	1.54e-07	20	56	4	ctd:C417207
Drug	phenanthridinone; Up 200; 51.2uM; MCF7; HT_HG-U133A_EA	BICD2 FLNB CELSR3 SUPT6H DLG3 IRX4	7.83e-06	193	56	6	1115_UP
Drug	Ketanserin tartrate hydrate [83846-83-7]; Up 200; 7uM; HL60; HG-U133A	FLNB JUN SUPT6H NFKB2 PKD2L1 TRAPPC9	9.07e-06	198	56	6	1593_UP
Drug	PCB 104	JUN NFKB1 NFKB2	9.35e-06	17	56	3	CID000091662
Drug	equol	JUN NFKB1 NFKB2 AR	1.54e-05	61	56	4	CID000091469
Drug	wogonin	JUN KRT8 NFKB1 NFKB2	1.75e-05	63	56	4	CID005281703
Drug	Cosopt	JUN NFKB1 NFKB2 POU3F1 HERC2 MAPK7 USF1	1.96e-05	341	56	7	CID000003154
Drug	AC1L1A4O	JUN KRT8 NFKB1 NFKB2	1.99e-05	65	56	4	CID000025967
Drug	AC1LA1RA	JUN NFKB1 NFKB2	2.10e-05	22	56	3	CID000479966
Drug	AR E	JUN ILF3 NFKB1 NFKB2 USF1 AR	2.12e-05	230	56	6	CID004369394
Drug	NSC-695672	NFKB1 NFKB2 AR TLX2	2.24e-05	67	56	4	CID000393593
Drug	pyrithione	KRT8 NFKB1 NFKB2	2.75e-05	24	56	3	CID000001569
Drug	panepoxydone	JUN NFKB1 NFKB2	3.12e-05	25	56	3	CID000161704
Drug	Velcade (bortezomib	JUN KRT8 KRT35 NFKB1 NFKB2 PSMD1 MAPK7	3.54e-05	374	56	7	CID000093860
Drug	tolrestat	KRT8 NFKB1 NFKB2 AR	4.09e-05	78	56	4	CID000053359
Drug	AC1MHEOC	JUN NFKB1 NFKB2	4.42e-05	28	56	3	CID003003140
Drug	AC1O3R20	JUN NFKB1 NFKB2	4.42e-05	28	56	3	CID006335051
Drug	1pzj	JUN MOGS NFKB1 NFKB2 MAPK7	5.64e-05	167	56	5	CID000447976
Drug	pyrrolidinium	MOGS NAPRT NFKB1 NFKB2	5.73e-05	85	56	4	CID000031268
Drug	NSC294601	NFKB1 NFKB2	5.91e-05	5	56	2	CID000325606
Drug	AC1MVXUL	NFKB1 NFKB2	5.91e-05	5	56	2	CID003715266
Drug	cephadroxil	HOXA7 HOXB1 HOXB3 AR	6.00e-05	86	56	4	CID000002610
Drug	BMS-345541	JUN NFKB1 NFKB2	6.65e-05	32	56	3	CID009813758
Drug	BiM4	JUN ILF3 CELSR3 NFKB1 NFKB2 MAPK7	6.74e-05	283	56	6	CID000002399
Drug	2,6-dihydroxybenzoic acid	HOXB1 JUN NFKB1 NFKB2 AR	7.05e-05	175	56	5	CID000009338
Drug	panduratin A	JUN NFKB1 NFKB2	7.30e-05	33	56	3	CID006483648
Drug	genistein	HSPG2 JUN KRT8 ILF3 PILRB NFKB1 NFKB2 LMAN2 MAPK7 PZP AR	7.35e-05	1117	56	11	CID005280961
Drug	trinitrobenzene	JUN KRT8 NFKB1 NFKB2	7.81e-05	92	56	4	CID000007434
Drug	pyrrole-2-carboxamide	JUN AR	8.86e-05	6	56	2	CID000573553
Drug	apocynin	JUN NFKB1 NFKB2 MAPK7 TLX2	9.40e-05	186	56	5	CID000002214
Drug	AC1O3GBZ	MOGS NFKB1 NFKB2	9.50e-05	36	56	3	CID006327751
Drug	celastrol; Down 200; 2.5uM; MCF7; HT_HG-U133A_EA	BICD2 CELSR3 DLG3 TRAPPC9 EPN2	9.64e-05	187	56	5	887_DN
Drug	sIL-4R	JUN NFKB1 NFKB2	1.03e-04	37	56	3	CID000059757
Drug	ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A	BICD2 HSPG2 JUN ILF3 MAPK7	1.17e-04	195	56	5	6918_UP
Drug	Chlorzoxazone [95-25-0]; Up 200; 23.6uM; HL60; HG-U133A	HOXB1 NFKB2 PKD2L1 DLG3 TRAPPC9	1.20e-04	196	56	5	1416_UP
Drug	Phenindione [83-12-5]; Down 200; 18uM; MCF7; HT_HG-U133A	JUN CELSR3 SUPT6H ANTXR1 TRAPPC9	1.23e-04	197	56	5	2868_DN
Drug	Cortodoxone	NFKB1 AR	1.24e-04	7	56	2	ctd:D003350
Drug	AC1L1GSB	JUN NFKB1 NFKB2	1.31e-04	40	56	3	CID000003819
Drug	E-guggulsterone	JUN NFKB1 NFKB2 AR	1.45e-04	108	56	4	CID006439929
Drug	SKF 38393	JUN CELSR3 NFKB1 NFKB2	1.56e-04	110	56	4	CID000001242
Drug	A 285	NFKB1 NFKB2 POU3F1	1.62e-04	43	56	3	CID000002340
Drug	AG 1879	HOXA7 JUN NFKB1 MAPK7	1.73e-04	113	56	4	ctd:C412373
Drug	1'-acetoxychavicol acetate	JUN NFKB1 NFKB2	1.74e-04	44	56	3	CID000119104
Drug	Dimethyl Sulfoxide	JUN KRT8 NFKB2 OCLN PZP AR	1.75e-04	337	56	6	ctd:D004121
Drug	AC1L1KON	JUN ILF3 NFKB1 NFKB2	1.85e-04	115	56	4	CID000005589
Drug	Acetaldehyde	HOXB1 JUN NFKB1 NFKB2 OCLN	2.10e-04	221	56	5	ctd:D000079
Drug	biphenylcarboxylic acid	JUN NFKB1	2.12e-04	9	56	2	CID000070357
Drug	heme arginate	JUN NFKB2	2.12e-04	9	56	2	ctd:C048849
Drug	2-oxothiazolidine-4-carboxylate	JUN NFKB1 NFKB2	2.12e-04	47	56	3	CID000065272
Drug	Malathion	JUN NFKB2 OCLN AR	2.25e-04	121	56	4	ctd:D008294
Drug	NSC364150	JUN NFKB1 NFKB2	2.25e-04	48	56	3	CID000100771
Disease	opportunistic bacterial infectious disease (implicated_via_orthology)	NFKB1 NFKB2	1.17e-04	9	54	2	DOID:0050340 (implicated_via_orthology)
Disease	Immunoglobulin Deficiency, Late-Onset	NFKB1 NFKB2	1.79e-04	11	54	2	C2936665
Disease	Acquired Hypogammaglobulinemia	NFKB1 NFKB2	1.79e-04	11	54	2	C2936664
Disease	Common variable immunodeficiency	NFKB1 NFKB2	2.53e-04	13	54	2	cv:C0009447
Disease	lysophosphatidylcholine 16:1 measurement	PKD2L1 MEX3B	2.95e-04	14	54	2	EFO_0010358
Disease	Common Variable Immunodeficiency	NFKB1 NFKB2	3.40e-04	15	54	2	C0009447
Disease	interleukin 18 measurement	PRR12 NAPRT OCLN	3.71e-04	76	54	3	EFO_0004581
Disease	Breast Carcinoma	JUN KRT8 ARID1B HERC2 OCLN AR	4.40e-04	538	54	6	C0678222
Disease	osteochondrodysplasia (is_implicated_in)	HSPG2 FLNB	5.51e-04	19	54	2	DOID:2256 (is_implicated_in)
Disease	Hirschsprung Disease	ARID1B CELSR3	1.48e-03	31	54	2	C0019569

Protein segments in the cluster

Peptide	Gene	Start	Entry
PTVDASYYGGRGVGG	ANTXR1	376	Q9H6X2
YYREGQGGAGRTSPG	BICD2	556	Q8TD16
YYGSAAPASGGPGGR	ARID1B	316	Q8NFD5
YGGSSAGYGVLSSPR	ARID1B	441	Q8NFD5
SPAAAGYVTAGGYGY	RBM24	181	Q9BX46
VSAGAVGQGYYGAGL	PZP	691	P20742
EGSGGNDAPGQYGAY	HSPG2	4191	P98160
SAAALGVYGGPYGGS	IRX4	66	P78413
RGYGTSLLGGSVGYP	OCLN	91	Q16625
SLLGGSVGYPYGGSG	OCLN	96	Q16625
AYGGLTSPGLSYSLG	KRT8	426	P05787
SGTPKGSGAGYGVGF	MAPK7	731	Q13164
GGYSDGLGGNSLYSP	PBX3	386	P40426
YGHTGYGPSGGSRKS	FLG2	2356	Q5D862
RLPTGYYFGASAGTG	LMAN2	246	Q12907
SAGAGATAGPGLGLY	GFI1	186	Q99684
ATAGPGLGLYGDFGS	GFI1	191	Q99684
AGGAAVGLGALCYYG	GHITM	86	Q9H3K2
AGGADYGFLGSGPAY	HOXD1	101	Q9GZZ0
LYATGYGAGGRLGIG	HERC2	4006	O95714
LSSGGGAPSYGAAGL	JUN	181	P05412
YGKAGGSPASYHGSP	EPN2	186	O95208
GYGVCTGPGAQGEYS	JPH4	26	Q96JJ6
SGSVSAYGPGLVYGV	FLNB	1821	O75369
LGLYAQAAYPGGGGG	POU3F1	156	Q03052
GGYHSPGDSATGIYG	GOLGA6L3	61	A6NEY3
GGYHSPGDSATGIYG	GOLGA6L4	61	A6NEF3
GGYHSPGDSATGIYG	GOLGA6L9	61	A6NEM1
GGYHSPGDSATGIYG	GOLGA6L10	61	A6NI86
GGYHSPGDSATGVYG	GOLGA6L19	61	H0YKK7
CLPAGGFATSYSGGG	KRT35	71	Q92764
GGGEAGAVAPYGYTR	AR	471	P10275
SGLLGGIGYFYGQGL	MOGS	396	Q13724
SYASEGRYGGGLSSP	HOXB1	41	P14653
YGSGGASYNPGSHGG	ILF3	821	Q12906
ASYNPGSHGGYGGGS	ILF3	826	Q12906
GGYSSYPGSNGFGFD	HOXB3	16	P14651
GASAGYGGYSSQTLP	DLG3	46	Q92796
SQTAGYLTGPGVAGY	DNAJC13	2201	O75165
GYGSCGFPSLGYGSG	KRTAP13-2	131	Q52LG2
GPSAAPEYAAGYGGG	FIGNL2	151	A6NMB9
AVPAASYGRIYAGGG	CELSR3	3041	Q9NYQ7
GGSSAGVGSLAFYPG	PRDM13	276	Q9H4Q3
GAGAGAFASTVPGLY	HOXA7	41	P31268
LVGSYGTSPEGIGGY	PIP4K2C	321	Q8TBX8
RSDPGGGGLAYAAYA	MEX3B	461	Q6ZN04
TSPGSAYQEGGGLYA	PSMD1	431	Q99460
APPGAGSYAAGAGGY	PRR12	601	Q9ULL5
SGYGGLPYGAAAAAA	SOX1	271	O00570
YGGSGGGSSAYHVFP	SUPT6H	1591	Q7KZ85
GGYSSQPGGYPATGA	YIF1A	31	O95070
GTLGYAIGGTYLGPA	SPSB2	176	Q99619
PDGGLTASTYSYLGG	NAPRT	176	Q6XQN6
PGGSTGSGPSYLYGV	PILRB	21	Q9UKJ0
SGGGYYLDLPGSRQG	PKD2L1	266	Q9P0L9
YHYPGGTGGKSGARR	TRAPPC9	256	Q96Q05
PGYGGAASAGASVFG	USP13	706	Q92995
SGGYHGASGYGPAGS	TLX2	51	O43763
YTYFPSTAVGDGAGG	USF1	116	P22415
TAPAYSFGIAGAGSG	JMJD8	161	Q96S16
TLYAAAGGGGASPDY	NEUROD2	276	Q15784
GTGSTGPGYSFPHYG	NFKB1	396	P19838
GGGGSLGFFPSSLAY	NFKB2	371	Q00653